Get the Stockscreener App
18.02
0.00%
0.00
After Hours:
18.02
Assertio Holdings Inc stock is traded at $18.02, with a volume of 430.45K.
It is up +0.00% in the last 24 hours and up +56.15% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers.
See More
Previous Close:
$18.02
Open:
$18.03
24h Volume:
430.45K
Relative Volume:
3.93
Market Cap:
$116.32M
Revenue:
$118.71M
Net Income/Loss:
$-30.38M
P/E Ratio:
-6.122
EPS:
-2.9435
Net Cash Flow:
$-28.18M
1W Performance:
-2.12%
1M Performance:
+56.15%
6M Performance:
+39.59%
1Y Performance:
+90.87%
1-Day Range:
$18.01
$18.07
1-Week Range:
$18.01
$18.15
52-Week Range:
$8.5515
$20.45
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
18.02 | 116.32M | 118.71M | -30.38M | -28.18M | -2.9435 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio (ASRT) divests INDOCIN, SPRIX and other brands in $35M Cosette deal - Stock Titan
Halper Sadeh Investigates Assertio Sale to Garda Therapeutics - Intellectia AI
ASRT SEC FilingsAssertio Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adeq - The National Law Review
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc.ASRT - The AI Journal
Is Assertio Holdings Inc a strong candidate for buy and holdPortfolio Risk Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders - Bluefield Daily Telegraph
Assertio to Be Acquired by Garda in Cash Deal - The Globe and Mail
Texas Instruments To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
HC Wainwright & Co. downgrades Assertio Holdings (ASRT) - MSN
Assertio Holdings to Be Acquired by Garda Therapeutics for $125.1 Million in All-Cash Deal Plus CVR - Minichart
Garda to acquire Assertio (Nasdaq: ASRT) in $125.1M cash deal plus CVR - Stock Titan
Assertio Agrees To Buyout By Garda Therapeutics - Citeline News & Insights
Assertio Holdings, Inc. (ASRT) Stock forecasts - Yahoo Finance UK
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT) - PR Newswire
Lake Forest pharma Assertio agrees to $125M take private deal, $35M drug sale - Crain's Chicago Business
Assertio Holdings to Be Acquired by Garda Therapeutics for $18 Per Share in All-Cash Deal, Plus CVR, Following Strategic Asset Sale to Cosette Pharmaceuticals 123 - Minichart
Lake Street cuts Assertio stock rating on acquisition deal - Investing.com
Lake Street cuts Assertio stock rating on acquisition deal By Investing.com - Investing.com Australia
Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect? - Yahoo Finance
Cosette Pharmaceuticals agrees to purchase of Assertio Holdings product portfolio - ROI-NJ
H.C. Wainwright cuts Assertio stock rating on Garda acquisition By Investing.com - Investing.com Australia
Assertio to Be Acquired by Garda for $18/Share Plus CVR; Sells Brands to Cosette for $35 Million - TradingView — Track All Markets
Assertio (Nasdaq: ASRT) agrees to $18 cash sale to Garda plus CVR upside - Stock Titan
H.C. Wainwright cuts Assertio stock rating on Garda acquisition - Investing.com
Cosette expands portfolio through Assertio product acquisitions - The Pharma Letter
Garda Therapeutics to acquire Assertio - The Pharma Letter
Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year? - qz.com
Lake Street downgrades Assertio Holdings (ASRT) - MSN
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio - BioSpace
ASRT stock drops after-hours on discounted buyout deal - MSN
Cosette acquires seven branded drugs from Assertio for $48.9M By Investing.com - Investing.com Canada
Assertio agrees to $125.1M sale to Garda Therapeutics - Investing.com
Cosette acquires seven branded drugs from Assertio for $48.9M - Investing.com
Assertio to Be Acquired by Garda Therapeutics for $125.1 Million Plus Contingent Value Right - marketscreener.com
Assertio agrees to $125.1M sale to Garda Therapeutics By Investing.com - Investing.com India
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN - Business Wire
Assertio Announces Agreement to be Acquired by Garda Therapeutics - The Chronicle-Journal
Aug Swings: Can Assertio Holdings Inc deliver consistent dividends2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Garda Therapeutics entered into a definitive agreement to acquire Assertio Holdings, Inc. for approximately $140 million. - marketscreener.com
Nantahala Capital reports 692,335 shares in Assertion Holdings (ASRT) - Stock Titan
[ARS] Assertio Holdings, Inc. SEC Filing - Stock Titan
Assertio: Why I'm Selling The Rally (Rating Downgrade) - Seeking Alpha
Executive pay, equity plan and auditor on ballot at Assertio (NASDAQ: ASRT) meeting - Stock Titan
ASRT Stock Price, Quote & Chart | ASSERTIO HOLDINGS INC (NASDAQ:ASRT) - ChartMill
Top 2 Health Care Stocks That May Implode In April - Sahm
ASRT PE Ratio & Valuation, Is ASRT Overvalued - Intellectia AI
Guidance Update: Is Assertio Holdings Inc a defensive stockWeekly Stock Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Assertio Holdings announces 1-for-15 reverse stock split - MSN
Aug Wrap: Will Assertio Holdings Inc stock go up in YEAR2026 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Assertio Holdings (ASRT) Issues 2026 Sales Guidance After Wider 2025 Losses Has The Bull Case Changed? - Yahoo Finance
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assertio Holdings Inc Stock (ASRT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Patel Ajay | EVP and CFO |
Feb 21 '26 |
Option Exercise |
0.00 |
1,143 |
0 |
16,508 |
| Schwichtenberg Paul | President and COO |
Feb 21 '26 |
Option Exercise |
0.00 |
1,143 |
0 |
14,553 |
| Schlessinger Sam | EVP, General Counsel |
Feb 18 '26 |
Option Exercise |
0.00 |
2,778 |
0 |
15,344 |
| Schwichtenberg Paul | President and COO |
Feb 18 '26 |
Option Exercise |
0.00 |
2,778 |
0 |
14,787 |
| Patel Ajay | EVP and CFO |
Feb 18 '26 |
Option Exercise |
0.00 |
2,778 |
0 |
16,742 |
| Schlessinger Sam | EVP, General Counsel |
Feb 07 '26 |
Option Exercise |
0.00 |
1,389 |
0 |
13,185 |
| Schwichtenberg Paul | President and COO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
12,834 |
| Patel Ajay | EVP and CFO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
14,789 |
| Stark David Matthew | Director |
Nov 10 '25 |
Sale |
0.76 |
8,959 |
6,806 |
98,541 |
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):